2008•Central Plains Medical JournalRequires access

Effects of trimetazidine on plasma level of brain natriuretic peptide and clinical value of BNP in patients with chronic heart failure

Xiaosheng Fan, Bo Yin

Open publisher page 0 citations

Abstract

Objective To observe the effects of trimetazidine on changes of plasma brain natriuretic peptide(BNP)and the clinical value of BNP in the diagnosis of chronic heart failure(CHF).Methods Sixtyeight patients with CHF were randomly divided into trimetazidine group and the conventional group,patients in the trimetazidine group were given trimetazidine 20 mg,tid,for 4 weeks.NYHA functional class,plasma BN-Pand echocardiographic indices(LVEDD,LVMI,LVEF)were evaluated before and after 4 weeks'therapy.Results After 4 weeks therapy,compared with the patients in the conventional group,trimetazidine improve cardiac function and reduce the Ievel of plasma BNP significantly.Conclusion Trimetazidine might improve cardiac function and reduce the level of plasma BNP in CHF patients,and plasma BNP might serve as a good indicator for evaluation of CHF and therapy in CHF patients. Key words: Heart failure; Trimetazidine; Brain natriuretic peptide

About this research paper

What this paper is about

Objective To observe the effects of trimetazidine on changes of plasma brain natriuretic peptide(BNP)and the clinical value of BNP in the diagnosis of chronic heart failure(CHF).Methods Sixtyeight patients with CHF were randomly divided into trimetazidine group and the conventional group,patients in the trimetazidine group were given trimetazidine 20 mg,tid,for 4 weeks.NYHA functional class,plasma BN-Pand echocardiographic indices(LVEDD,LVMI,LVEF)were evaluated before and after 4 weeks'therapy.Results After 4 weeks therapy,compared with the patients in the conventional group,trimetazidine improve cardiac function and reduce the Ievel of plasma BNP significantly.Conclusion Trimetazidine might improve cardiac function and reduce the level of plasma BNP in CHF patients,and plasma BNP might serve as a good indicator for evaluation of CHF and therapy in CHF patients. Key words: Heart failure; Trimetazidine; Brain natriuretic peptide

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of trimetazidine on changes of plasma brain natriuretic peptide(BNP)and the clinical value of BNP in the diagnosis of chronic heart failure(CHF).Methods Sixtyeight patients with CHF were randomly divided into trimetazidine group and the conventional group,patients in the trimetazidine group were given trimetazidine 20 mg,tid,for 4 weeks.NYHA functional class,plasma BN-Pand echocardiographic indices(LVEDD,LVMI,LVEF)were evaluated before and after 4 weeks'therapy.Results After 4 weeks therapy,compared with the patients in the conventional group,trimetazidine improve cardiac function and reduce the Ievel of plasma BNP significantly.Conclusion Trimetazidine might improve cardiac function and reduce the level of plasma BNP in CHF patients,and plasma BNP might serve as a good indicator for evaluation of CHF and therapy in CHF patients. Key words: Heart failure; Trimetazidine; Brain natriuretic peptide

Key concepts: Trimetazidine, Medicine, Brain natriuretic peptide, Internal medicine, Cardiology, Heart failure, Ejection fraction, Natriuretic peptide

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of trimetazidine on plasma level of brain natriuretic peptide and clinical value of BNP in patients with chronic heart failure — Research Paper | ScholarLens